Sign in Subscribe
Stock offerings

Guangzhou Wondfo Biotech's Trading Risk Assessment Downgraded to Level 1

Strategic Insights

— 1 min read

Guangzhou Wondfo Biotech's trading risk has been assessed and downgraded to Level 1, indicating the lowest possible risk of experiencing downward price swings. This rating is based on a detailed analysis of six key factors, including margin trading, stock lending, and shareholder activity. The company's free-float ratio is 70.41%, and it has no shares frozen under court custody, pledged, or mortgaged for financing purposes.

Key Takeaways:

  • Guangzhou Wondfo Biotech's trading risk has been downgraded to Level 1, indicating a low risk of downward price swings.
  • The company's free-float ratio is 70.41%, with a total number of free-float and outstanding shares of 241,285,742 and 342,680,193, respectively.
  • There are no shares frozen under court custody, pledged, or mortgaged for financing purposes.
  • The company has announced plans to lift restrictions on the sale of its shares, with 0.93 million restricted shares allowed for sale, valued at RMB 62 million.
  • The number of restricted shares represents 0.27% of the outstanding shares and includes only Employees' Shares Options.
  • The company has received an "A" rating for outstanding bonds and trust products, indicating good cash reserves and a low risk of bond debt default.
  • In margin trading, Guangzhou Wondfo Biotech has a net position of 443,052 shares, with a monthly velocity of 4.38 and an annual average of 2.41.

Statistics:

  • 13.7% of 3,505 assessed companies have been placed at Level 1 trading risk, indicating a low risk of downward price swings.
  • The company has a total number of shares with long positions of 5,281,797 and a net position of 443,052 shares.
  • The monthly velocity of margin trading is 4.38, with an annual average of 2.41.
  • The company's free-float ratio is 70.41%, and the number of restricted shares represents 0.27% of the outstanding shares.

Sources:

  • China Knowledge (Dec 01, 2020) - Guangzhou Wondfo Biotech's trading risk assessment downgraded to Level 1.
  • Company records (Nov 27, 2020) - Guangzhou Wondfo Biotech's free-float ratio and number of restricted shares.
  • Company announcements (Nov 10, 2020) - Lifting restrictions on the sale of shares.
  • Margin trading data - Guangzhou Wondfo Biotech's net position and monthly velocity.

Read more